As of 2026-09-23, the Fair Value of Lexicon Pharmaceuticals Inc (LXRX) is -0.29 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.18 USD, the upside of Lexicon Pharmaceuticals Inc is -113.47%.
With the market price of 2.18 USD and our fair value calculation, Lexicon Pharmaceuticals Inc (LXRX) is not a good investment. Investing in LXRX stocks now will result in a potential loss of 113.47%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -87.80 | -101.90 | -177.12 | -200.40 | -50.34 | -123.51 |
| YoY growth | -49.83% | -16.06% | -73.82% | -13.15% | 74.88% | -15.59% |
| Market Cap (mil) | 968.36 |
| P/E | |
| Forward P/E |
| EPS | -0.06 |
| Avg earnings growth rate | -15.59% |
| TTM earnings | -26.09 |